Witnessing the stock’s movement on the chart, on July 14, 2020, Helius Medical Technologies Inc. (NASDAQ: HSDT) set off with pace as it heaved 10.38% to $0.54. During the day, the stock rose to $0.619 and sunk to $0.475 before settling in for the price of $0.49 at the close. Taking a more long-term approach, HSDT posted a 52-week range of $0.25-$2.42.
Meanwhile, its Annual Earning per share during the time was 15.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 70.50%. This publicly-traded company’s shares outstanding now amounts to $38.04 million, simultaneously with a float of $30.92 million. The organization now has a market capitalization sitting at $20.21 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4979, while the 200-day Moving Average is $0.7595.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 19 employees. It has generated 78,737 per worker during the last fiscal year. Meanwhile, its income per employee was -514,789. The stock had 3.52 Receivables turnover and 0.08 Total Asset turnover. For the Profitability, stocks gross margin was +39.17, operating margin was -1604.01 and Pretax Margin of -653.81.
Helius Medical Technologies Inc. (HSDT) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Helius Medical Technologies Inc.’s current insider ownership accounts for 0.60%, in contrast to 20.00% institutional ownership.
Helius Medical Technologies Inc. (HSDT) Earnings and Revenue Records
As on 6/29/2017, Multinational firm has announced its last quarter scores, in which it reported -$0.3 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.05) by -$0.25. This company achieved a net margin of -653.81 while generating a return on equity of -124.69. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Helius Medical Technologies Inc.’s EPS increase for this current 12-month fiscal period is 70.50% and is forecasted to reach -0.49 in the upcoming year.
Helius Medical Technologies Inc. (NASDAQ: HSDT) Trading Performance Indicators
Let’s observe the current performance indicators for Helius Medical Technologies Inc. (HSDT). It’s Quick Ratio in the last reported quarter now stands at 1.70. The Stock has managed to achieve an average true range (ATR) of 0.06. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 20.21.
In the same vein, HSDT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.57, a figure that is expected to reach -0.12 in the next quarter, and analysts are predicting that it will be -0.49 at the market close of one year from today.
Technical Analysis of Helius Medical Technologies Inc. (HSDT)
Going through the that latest performance of [Helius Medical Technologies Inc., HSDT]. Its last 5-days volume of 1.16 million indicated improvement to the volume of 0.78 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 62.04% While, its Average True Range was 0.0552.
Raw Stochastic average of Helius Medical Technologies Inc. (HSDT) in the period of the previous 100 days is set at 47.75%, which indicates a major fall in contrast to 65.27% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 94.04% that was lower than 154.62% volatility it exhibited in the past 100-days period.